It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are ...

The Gates Foundation is doubling down on its support for women's health research, pumping $2.5 billion between now and the ...

Around 240,000 people are expected to be offered Mounjaro over the next three years, according to NICE, which has recommended ...

Nalvee marks a return to the market for a dydrogesterone-only product after an absence of 17 years, and can be used in ...

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...

The list of bodies that have been ousted from Advisory Committee on Immunization Practices (ACIP) workgroups includes ...

Grant funding calls are often over-subscribed and success rates can be low. Excellent applications sometimes fail to be ...

As excitement builds around GLP-1s and their expanding list of potential indications, the conversation is shifting from hype ...

Don't fall behind. Take a step toward becoming indispensable to your organization by attending our no-cost* LEAN Cell & Gene Boston Summit on Monday, September 22, conveniently planned just one day ...

The UK has started a 'world-first' gonorrhoea vaccination programme that is designed to prevent thousands of cases and save ...

Vertex already has FDA approval for NaV1.8 inhibitor Journavx (suzetrigine) in acute pain, with late-stage trials on the go ...

President Donald Trump has given leading pharma manufacturers a 60-day deadline to come up with a most favoured nation (MFN) ...